More 2022 predictions. These focus on patient experience – not just a buzz phrase but a real driver of innovation and digital change. Engagement technology and tools for patients in every aspect of their health journey needs to be considered and available.
Read More
The U.S. Department of Health and Human Services, through the Health Resources and Services Administration, announced the distribution of approximately $9 billion in Provider Relief Fund Phase 4 payments to health care providers who have experienced revenue losses and expenses related to the COVID-19 pandemic.
By Joy Rios – The MIPS 2022 Final Rule has been released and here is a breakdown of what you need to know about the program, overall and by category. For the 2022 performance year, to avoid a penalty eligible clinicians must earn a score of at least 75 points.
In case you missed it, this is recent communication from the Centers for Medicare & Medicaid Services. Subscribe to their email lists to keep up to date on all press and news releases.
Interoperability thirteen years in. 2021 did bring us the information blocking final rule and pandemic is still looming over healthcare and delivery. As always the health IT community continues to be bullish on interoperability solutions, but will we get there in 2022?
A new report from the U.S. Department of Health and Human Services found that massive increases in the use of telehealth helped maintain some health care access during the COVID-19 pandemic, with specialists like behavioral health providers seeing the highest telehealth utilization relative to other providers.
As 2021 comes to an end we like to reach out to our thought leaders to see what they think we can expect next year. So what should we look forward to when it comes to Big Data, Analytics, and AI in health IT?
Supporting the adoption of health IT and the promotion of nationwide health information exchange to improve health care, here is what is happening at the ONC, including several upcoming events to register for this week, including the Health IT Developer Certification & Testing Roundtable, the Information Sharing Virtual Office Hours & more.
By JoNel Aleccia – Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic — with a second option from Pfizer to follow shortly after.